Bjerrum Andreas, Andersen Ole, Fischer Anders, Lindebjerg Jan, Lynge Elsebeth
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Copenhagen University Hospital Herlev, Herlev, Denmark.
Int J Cancer. 2017 Aug 1;141(3):503-511. doi: 10.1002/ijc.30756. Epub 2017 May 15.
Faecal occult blood test (FOBT) screening for colorectal cancer (CRC) is implemented in several countries. Approximately half of all screen positive persons have negative colonoscopy, but consensus is lacking on how these persons should be followed up. Health authorities in Denmark and The Netherlands recommend suspending screening for 8-10 years, while patients in UK are invited to screening after 2 years. In this cohort-study, we followed 166,277 individuals invited to FOBT-screening in 2005-2006 and a reference group comprising the remaining 1,240,348 Danes of the same age. We linked Danish population and health service registers to obtain information about colonoscopy outcome and incident CRC. We estimated CRC risk by colonoscopy outcome (adenoma, other colorectal pathology or negative colonoscopy) for the reference group, the screening group, and subgroups. Persons with positive screening FOBT followed by negative colonoscopy had the same long-term CRC risk as persons with adenoma detected due to a positive screening FOBT (aHR 1.33, 95% CI: 0.65-2.71). We found no difference in the long-term CRC risk between persons with negative colonoscopy after a positive FOBT screening test and the unscreened reference population (aHR 1.05, 95% CI: 0.62-1.78). Since FOBT screen positive persons in our study remained at average risk of CRC despite of a negative index colonoscopy, we question the safety of suspending FOBT screening for this group. It needs to be monitored whether recent efforts to improve colonoscopy quality have been successful in ensuring low CRC risk after negative colonoscopy also in FOBT positive persons.
几个国家实施了粪便潜血试验(FOBT)筛查结直肠癌(CRC)。所有筛查呈阳性的人中约有一半结肠镜检查结果为阴性,但对于如何对这些人进行后续随访尚无共识。丹麦和荷兰的卫生当局建议暂停筛查8至10年,而英国的患者在2年后被邀请参加筛查。在这项队列研究中,我们跟踪了2005年至2006年被邀请参加FOBT筛查的166,277人以及由其余1,240,348名同龄丹麦人组成的参照组。我们将丹麦人口和卫生服务登记册相链接,以获取有关结肠镜检查结果和结直肠癌发病情况的信息。我们根据参照组、筛查组及其亚组的结肠镜检查结果(腺瘤、其他结直肠病变或结肠镜检查阴性)估计结直肠癌风险。FOBT筛查呈阳性但结肠镜检查结果为阴性的人与因FOBT筛查呈阳性而检测出腺瘤的人具有相同的长期结直肠癌风险(风险比1.33,95%置信区间:0.65 - 2.71)。我们发现,FOBT筛查呈阳性后结肠镜检查结果为阴性的人与未筛查的参照人群在长期结直肠癌风险上没有差异(风险比1.05,95%置信区间:0.62 - 1.78)。由于在我们的研究中,尽管初次结肠镜检查结果为阴性,但FOBT筛查呈阳性的人仍处于结直肠癌的平均风险水平,因此我们质疑对该组人群暂停FOBT筛查的安全性。需要监测近期提高结肠镜检查质量的努力是否成功确保了FOBT呈阳性的人在结肠镜检查结果为阴性后也具有较低的结直肠癌风险。